Literature DB >> 22670601

Mini-review: spinocerebellar ataxias: an update of SCA genes.

Alexis Trott1, Lucien J Houenou.   

Abstract

Autosomal dominant spinocerebellar ataxias (SCAs) are a complex group of debilitating and neurodegenerative diseases that affect the cerebellum and its main connections and characterized by a generalized incoordination of gait, speech, and limb movements. In general, the onset of SCAs occurs during adult life and shows great clinical heterogeneity. Currently, the mutations responsible for different types of SCAs have been localized in different regions of the genome, and most of them were already mapped and cloned. Several pieces of evidence suggest that all these diseases share the same molecular mechanism and physiopathological processes. CAG trinucleotide expansion is a common mutational basis of several of these disorders. An expanded polyglutamine tract may become a toxic product when located within the coding region of the gene. The SCA genes, recent patents and the molecular aspects of these disorders are presented in this review. Our knowledge of the molecular mechanisms of SCAs is rapidly expanding, and the development of important studies is bringing hope for effective therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670601     DOI: 10.2174/187221512801327442

Source DB:  PubMed          Journal:  Recent Pat DNA Gene Seq        ISSN: 1872-2156


  8 in total

Review 1.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 2.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

Review 3.  Recent advances in the genetic etiology of brain malformations.

Authors:  David A Dyment; Sarah L Sawyer; Jodi Warman Chardon; Kym M Boycott
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

Review 4.  Glycosaminoglycans in Neurodegenerative Diseases.

Authors:  Weihua Jin; Fuming Zhang; Robert J Linhardt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  An Improved Method for Differentiating Mouse Embryonic Stem Cells into Cerebellar Purkinje Neurons.

Authors:  Christopher J Alexander; John A Hammer
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

6.  An understanding of spinocerebellar ataxia.

Authors:  N B Ramachandra; L Kusuma
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

Review 7.  Ataxia in children: early recognition and clinical evaluation.

Authors:  Piero Pavone; Andrea D Praticò; Vito Pavone; Riccardo Lubrano; Raffaele Falsaperla; Renata Rizzo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2017-01-13       Impact factor: 2.638

Review 8.  Spinocerebellar ataxia type 23 (SCA23): a review.

Authors:  Fan Wu; Xu Wang; Xiaohan Li; Huidi Teng; Tao Tian; Jing Bai
Journal:  J Neurol       Date:  2020-11-11       Impact factor: 6.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.